Related Experiment Video
Updated: Aug 13, 2025
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary
Thilo Gambichler1, Lyn G Brüggestrat1, Marina Skrygan1
1Skin Cancer Center, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany.
Abstract:
Merkel cell carcinoma (MCC) is a rare, difficult-to-treat skin cancer once immunotherapy has failed. MCC is associated either with the clonal integration of the Merkel cell polyomavirus (MCPyV) or mutagenic UV-radiation. Fumaric acid esters, including dimethyl fumarate (DMF), have been shown to inhibit cell growth in cutaneous melanoma and lymphoma. We aimed to explore the effects of DMF on MCPyV-negative MCC cell lines. Three MCC cell lines (MCC13, MCC14.2, and MCC26) were treated with different doses of DMF. The cytotoxic effects and cell proliferation were assessed by the MTT cytotoxicity assay and BrdU proliferation assay at different time points. A significant reduction in cell viability and proliferation were demonstrated for all the cell lines used, with DMF proving to be effective.
Insights
Dimethyl fumarate (DMF) effectively reduced cell viability and proliferation in Merkel cell carcinoma (MCC) cell lines. This study highlights DMF as a potential therapeutic agent for MCC, particularly when other treatments fail.
Area of Science:
- Oncology
- Dermatology
- Virology
Background:
- Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer with limited treatment options after immunotherapy failure.
- MCC pathogenesis is linked to Merkel cell polyomavirus (MCPyV) or UV radiation.
- Fumaric acid esters, like dimethyl fumarate (DMF), have demonstrated anti-proliferative effects in other cancers.
Purpose of the Study:
- To investigate the efficacy of dimethyl fumarate (DMF) in inhibiting the growth of Merkel cell carcinoma (MCC) cell lines.
- To assess the impact of DMF on MCPyV-negative MCC cells, a subset of MCC patients.
Main Methods:
- Three distinct MCC cell lines (MCC13, MCC14.2, MCC26) were utilized.
- Cells were exposed to varying concentrations of DMF.
- Cytotoxicity and proliferation were evaluated using MTT and BrdU assays, respectively, over different time intervals.
Main Results:
- Dimethyl fumarate (DMF) significantly reduced cell viability across all tested MCC cell lines.
- DMF demonstrated a notable decrease in cell proliferation in the treated MCC cell lines.
- The compound proved effective in inhibiting the growth of MCPyV-negative MCC cells.
Conclusions:
- Dimethyl fumarate (DMF) exhibits significant cytotoxic and anti-proliferative effects on Merkel cell carcinoma (MCC) cell lines.
- DMF represents a promising therapeutic candidate for MCC treatment, especially in cases resistant to immunotherapy.
- Further research into DMF's mechanism and clinical application in MCC is warranted.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019